You are currently viewing a new version of our website. To view the old version click .

Molecular and Cellular Research on Rare Lung Diseases

This special issue belongs to the section “Molecular and Translational Medicine“.

Special Issue Information

Dear Colleagues,

Rare lung diseases are associated with high mortality and morbidity and a mean survival of about 5–6 years from the onset of symptoms. They are chronic, irreversible, progressive group of disorders associated with poor prognosis. It is difficult to diagnose due to similar clinical and radiological signs. Very few treatments are now available and lung transplantation is considered the best therapeutic option in end-stage and progressive form of disease. Risk factors can include smoking, genetic predisposition and environmental variables linked to pathological alteration of lung epithelium. The exact pathogenetic mechanisms leading to the development of these disorders are not fully understood. Molecular and cellular research on this field is useful for the study of these diseases since these aspects are fundamental in the pathogenesis and progression of rare lung disease.

Dr. Laura Bergantini
Dr. Miriana d'Alessandro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pulmonary fibrosis
  • rare lung diseases
  • lung transplant
  • biomarkers
  • bronchoalveolar lavage

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059